The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

Rachel Reeves’s tax raid pulled in £300m less than expected during its first two months of operation, the Office for Budget ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

London’s FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and ...

With Mark Read stepping down as WPP CEO this year, speculation is mounting about the internal candidates who might be ...

Since BlackRock’s appointment as Investment Manager on 1 April 2012. 4 Further details are given in the Glossary in the Half Yearly Financial Report. Equity market investors sought alternative assets ...

How are contractors meeting the challenges of designing life sciences buildings that are fit for the future? In south London, ...

AstraZeneca has unveiled plans to invest around ... The C$820 million investment revolves around a new, larger office facility in the Greater Toronto area and will see AZ's Canadian headcount ...